Interrupters of VAscular daMAge in Malignant Hypertension
NCT04991077
·
clinicaltrials.gov ↗
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Malignant Hypertension
Interventions
BIOLOGICAL:
analyse of angiogenic, vasoactive and VEGF systems
Sponsor
Centre Hospitalier de PAU